SPIRO ROMBOTIS joined Cyclacel Limited as Chief Executive Officer in
August 1997. He has 23 years of experience with pharmaceutical and
biotech companies. He was previously Vice President, International
Operations and Business Development, Managing Director, Europe and
Director, Japanese joint venture, all at The Liposome Company, Inc.;
Vice President, Pharmaceuticals, Central and Eastern Europe and Director
International Marketing, Bristol-Myers Squibb Company; Head European
Marketing and Sales, Head Corporate Development, Centocor, Inc.;
Business Development, Novartis AG. Mr. Rombotis holds a BA from Williams
College and an MBA and Master’s degree in Hospital Management with
honors from Kellogg Graduate School of Management, where he serves on
the Advisory Board, Kellogg Center for Biotechnology.
